Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
27604375
DOI
10.1007/s00345-016-1928-x
PII: 10.1007/s00345-016-1928-x
Knihovny.cz E-zdroje
- Klíčová slova
- Diagnosis, Epidemiology, New technologies, Predictive tools, Prognosis, Risk factor, UTUC,
- MeSH
- dědičné nepolypózní kolorektální nádory epidemiologie MeSH
- karcinom z přechodných buněk diagnostické zobrazování epidemiologie patologie chirurgie MeSH
- kyseliny aristolochové metabolismus MeSH
- ledvinná pánvička diagnostické zobrazování patologie chirurgie MeSH
- lidé MeSH
- lymfadenektomie MeSH
- nádory ledvin diagnostické zobrazování epidemiologie patologie chirurgie MeSH
- nádory močového měchýře epidemiologie MeSH
- nádory močovodu diagnostické zobrazování epidemiologie patologie chirurgie MeSH
- neoadjuvantní terapie MeSH
- předoperační péče MeSH
- prognóza MeSH
- rizikové faktory MeSH
- ureteroskopie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- aristolochic acid I MeSH Prohlížeč
- kyseliny aristolochové MeSH
PURPOSE: Upper-tract urothelial carcinoma (UTUC) is a relatively uncommon disease with limited available evidence on specific topics. The purpose of this article was to review the previous literature to summarize the current knowledge about UTUC epidemiology, diagnosis, preoperative evaluation and prognostic assessment. METHODS: Using MEDLINE, a non-systematic review was performed including articles between January 2000 and February 2016. English language original articles, reviews and editorials were selected based on their clinical relevance. RESULTS: UTUC accounts for 5-10 % of all urothelial cancers, with an increasing incidence. UTUC and bladder cancer share some common risk factors, even if they are two different entities regarding practical, biological and clinical characteristics. Aristolochic acid plays an important role in UTUC pathogenesis in certain regions. It is further estimated that approximately 10 % of UTUC are part of the hereditary non-polyposis colorectal cancer spectrum disease. UTUC diagnosis remains mainly based on imaging and endoscopy, but development of new technologies is rapidly changing the diagnosis algorithm. To help the decision-making process regarding surgical treatment, extent of lymphadenectomy and selection of neoadjuvant systemic therapies, predictive tools based on preoperative patient and tumor characteristics have been developed. CONCLUSIONS: Awareness regarding epidemiology, diagnosis, preoperative evaluation and prognostic assessment changes is essential to correctly diagnose and manage UTUC patients, thereby potentially improving their outcomes.
Department of Genitourinary Oncology Moffitt Cancer Center Tampa FL USA
Department of Surgery McGill University Montreal QC Canada
Department of Urology Bern University Hospital Bern Switzerland
Department of Urology Caritas St Josef Medical Centre University of Regensburg Regensburg Germany
Department of Urology Clinica Alemana Santiago Chile
Department of Urology Fudan University Shanghai Cancer Center Shanghai China
Department of Urology Keio University School of Medicine Tokyo Japan
Department of Urology Medical University of Vienna Vienna Austria
Department of Urology University Medical Center Hamburg Eppendorf Hamburg Germany
Department of Urology University of Texas Southwestern Medical Center Dallas TX USA
Department of Urology Weill Cornell Medical College New York NY USA
Karl Landsteiner Institute of Urology and Andrology Vienna Austria
Scott Department of Urology Baylor College of Medicine Houston TX USA
Urology Department University of Sao Paulo Medical School and Institute of Cancer São Paulo Brazil
Zobrazit více v PubMed
J Endourol. 2011 Jan;25(1):19-23 PubMed
BJU Int. 2012 Jan;109(1):77-82 PubMed
World J Urol. 2011 Aug;29(4):487-94 PubMed
Neoplasia. 2008 Mar;10(3):255-65 PubMed
Urol Oncol. 2014 Oct;32(7):981-8 PubMed
BJU Int. 2011 Oct;108(8 Pt 2):E304-9 PubMed
Int J Urol. 1995 Sep;2(4):243-8 PubMed
Eur Urol. 2012 Jul;62(1):100-14 PubMed
BJU Int. 2009 Feb;103(3):307-11 PubMed
Urol Oncol. 2013 Aug;31(6):904-8 PubMed
Cancer Cytopathol. 2014 Jun;122(6):459-67 PubMed
Urol Oncol. 2012 Nov-Dec;30(6):821-4 PubMed
Lancet Oncol. 2009 Apr;10(4):400-8 PubMed
BJU Int. 2011 Sep;108(5):701-5 PubMed
PLoS One. 2015 Nov 10;10(11):e0139976 PubMed
Eur Urol. 1999 Apr;35(4):318-22 PubMed
BJU Int. 2014 Jul;114(1):56-61 PubMed
BJU Int. 2011 Apr;107(7):1059-64 PubMed
Eur Urol. 2010 Jun;57(6):1072-9 PubMed
J Urol. 2013 Apr;189(4):1214-21 PubMed
Cancer Res. 1992 Jan 15;52(2):254-7 PubMed
J Endourol. 2014 Aug;28(8):922-5 PubMed
World J Urol. 2013 Feb;31(1):141-5 PubMed
J Ultrasound Med. 2010 Sep;29(9):1277-84 PubMed
World J Urol. 2011 Aug;29(4):481-6 PubMed
J Endourol. 2013 Dec;27(12):1450-4 PubMed
J Urol. 2010 Aug;184(2):453-8 PubMed
BJU Int. 2009 Nov;104(10):1436-40 PubMed
BJU Int. 2013 Sep;112(5):623-37 PubMed
Cancer. 2006 Feb 25;108(1):45-8 PubMed
Eur Urol. 2008 Dec;54(6):1226-36 PubMed
Proc Natl Acad Sci U S A. 2012 May 22;109 (21):8241-6 PubMed
Eur Urol. 2014 Aug;66(2):181-3 PubMed
Eur Urol. 2012 Feb;61(2):245-53 PubMed
Clin Genitourin Cancer. 2016 Feb;14 (1):e37-41 PubMed
Urology. 2011 Jul;78(1):82-6 PubMed
Urol Int. 2016;96(1):65-72 PubMed
Urol Oncol. 2011 Nov-Dec;29(6):716-23 PubMed
Eur Urol. 2015 Nov;68(5):868-79 PubMed
J Urol. 2012 Feb;187(2):424-8 PubMed
J Urol. 2013 Dec;190(6):2236-42 PubMed
N Engl J Med. 1998 Feb 12;338(7):446-52 PubMed
J Endourol. 2012 Apr;26(4):398-402 PubMed
BJU Int. 2010 Mar;105(6):799-804 PubMed
Cancer. 2009 Jul 1;115(13):2853-62 PubMed
Eur Radiol. 2006 Jun;16(6):1244-52 PubMed
Eur Urol. 2013 Jun;63(6):1082-90 PubMed
Radiology. 2008 May;247(2):451-7 PubMed
Eur Urol. 2010 Oct;58(4):574-80 PubMed
Photodiagnosis Photodyn Ther. 2016 Mar;13:255-60 PubMed
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30 PubMed
Eur J Radiol. 2010 Feb;73(2):334-8 PubMed
World J Urol. 2013 Feb;31(1):69-76 PubMed
J Urol. 2009 Nov;182(5):2177-81 PubMed
Urol Oncol. 2013 Nov;31(8):1696-700 PubMed
J Endourol. 2008 Jan;22(1):71-6 PubMed
J Endourol. 2015 Dec;29(12 ):1418-23 PubMed
World J Urol. 2016 Sep;34(9):1201-6 PubMed
J Urol. 2010 Jul;184(1):69-73 PubMed